Press Releases | Archives

October 28, 2011

TOSHIBA INTRODUCES "AIDR 3D", ROBUST DOSE MANAGEMENT SOFTWARE

Toshiba presents improved, dose-reduction software that lowers patient dose up to 75 percent, while providing better image quality routinely.

June 16, 2011

TOSHIBA MEDICAL SYSTEMS CORPORATION SUCCESSFULLY COMPLETES TENDER OFFER FOR OUTSTANDING SHARES OF VITAL IMAGES, INC

New York, New York, June 16, 2011 and Tokyo, Japan, June 16, 2011 - Toshiba Medical Systems Corporation ("TMSC") today announced the expiry of the subsequent offering period by TMSC and its wholly-owned subsidiary, Magenta Corporation ("Merger Sub"), for all of the outstanding shares of common stock of Vital Images, Inc. (Nasdaq: VTAL) ("Vital Images").

June 9, 2011

TOSHIBA MEDICAL SYSTEMS CORPORATION ANNOUNCES EXPIRATION OF INITIAL TENDER OFFER PERIOD FOR OUTSTANDING SHARES OF VITAL IMAGES, INC. AND COMMENCEMENT OF SUBSEQUENT OFFERING PERIOD

New York, New York, June 9, 2011 and Tokyo, Japan, June 9, 2011 - Toshiba Medical Systems Corporation ("TMSC") today announced the completion of the initial cash tender offer by TMSC and its wholly-owned subsidiary, Magenta Corporation ("Merger Sub"), for all of the outstanding shares of common stock of Vital Images, Inc. (Nasdaq: VTAL) ("Vital Images").

May 23, 2011

TOSHIBA MEDICAL SYSTEMS CORPORATION ANNOUNCES EARLY TERMINATION OF HSR WAITING PERIOD FOR ITS OFFER FOR SHARES OF VITAL IMAGES, INC.

New York, New York, May 23, 2011 and Tokyo, Japan, May 23, 2011 - Toshiba Medical Systems Corporation ("TMSC") today announced that, on May 20, 2011, the U.S. Federal Trade Commission granted early termination of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the "HSR Act") applicable to the cash tender offer by TMSC and its wholly-owned subsidiary, Magenta Corporation ("Merger Sub"), for all of the outstanding shares of common stock of Vital Images, Inc. (Nasdaq: VTAL) ("Vital Images").

May 11, 2011

TOSHIBA MEDICAL SYSTEMS CORPORATION COMMENCES CASH TENDER OFFER FOR ALL OUTSTANDING SHARES OF VITAL IMAGES, INC.

New York, New York, May 11, 2011 and Tokyo, Japan, May 11, 2011 - Toshiba Medical Systems Corporation ("TMSC") today announced that TMSC and its wholly-owned subsidiary, Magenta Corporation ("Merger Sub"), will commence today a cash tender offer for all of the outstanding shares of common stock of Vital Images, Inc. (Nasdaq: VTAL) ("Vital Images") at a price of $18.75 per share.

April 28, 2011

TOSHIBA MEDICAL SYSTEMS CORPORATION TO ACQUIRE VITAL IMAGES, INC. FOR $18.75 PER SHARE IN ALL CASH TRANSACTION

Vital signs merger agreement with TMSC; Combination to Strengthen TMSC's Global Healthcare Imaging Solutions Business

April 1, 2011

TOSHIBA MEDICAL SYSTEMS CORPORATION ACCELERATES ENVIRONMENTAL MANAGEMENT

Because we believe that preserving the irreplaceable global environment is a vital issue for management, Toshiba Medical Systems Corporation (Headquarters: Otawara, Tochigi, Japan; President: Satoshi Tsunakawa), has established an environmental management promotion system and is committed to continuous environmental activities.

March 28, 2011

SUPPORT FOR AFFECTED AREA BY THE TOHOKU EARTHQUAKE AND TSUNAMI TOSHIBA PROVIDES COMPACT PORTABLE DIAGNOSTIC ULTRASOUND SYSTEMS

Toshiba Medical Systems Corporation offered to provide 10 Viamo™, diagnostic ultrasound systems, to support reconstruction in affected area to the Japan Red Cross Society.

February 28, 2011

TOSHIBA MANUFACTURES MILESTONE 25,000TH CT SYSTEM AND BEGINS RESEARCH COLLABORATION WITH RADBOUD UNIVERSITY

In December 2010, Toshiba Medical Systems Corporation reached a new milestone with the manufacture of its 25,000th CT system.

January 19, 2011

TOSHIBA PRESENTS Aquilion PRIME, THE NEXT GENERATION MULTISLICE CT SCANNER.

The new 160-slice MDCT scanner, Aquilion™ PRIME is the latest addition to the Aquilion ONE™ family with the key feature "Adaptive Iterative Dose Reduction (AIDR)" an iterative reconstruction algorithm, which has been designed to further enhance clinical examinations.

January 11, 2011

TOSHIBA ANNOUNCES NON-CONTRAST MRA MULTI-CENTER TRIAL

Trial Will Include Comparisons between Non-Contrast Time-SLIP Angiography and Other Diagnostic Imaging Techniques, Including Digital Subtraction X-RAY Angiography in the Diagnosis of Renal Artery Stenosis

Contact Us